Corbus Pharma (CRBP) Advances to Session High, Up 33%

October 5, 2016 11:36 AM EDT
Get Alerts CRBP Hot Sheet
Trade CRBP Now!
Join SI Premium – FREE

Get access to the best calls on Wall Street with StreetInsider.com's Ratings Insider Elite. Get your Free Trial here.

Corbus Pharma (NASDAQ: CRBP) hit session highs heading into mid-day, extending gains after Cantor initiated coverage on the stock with a Buy rating and a price target of $17.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Momentum Movers, Trader Talk

Add Your Comment